Find and Pitch Jounalists, Get Your Story Covered

Tags: MDMA ecstasy PTSD therapy commerce e-commerce

	Profile	Recent Articles on Subject
1	Kristen Monaco MedPage Today	Psilocybin Paper Corrected; Fewer Psychiatrists Billing Medicare; Cannabis and Death - about 2 months ago Psych Congress Roundup: Digital Tx for MDD; Esketamine Rooms; PA Contributions - 5 months ago More ADHD Drug Production; Psilocybin vs Lexapro; Addiction a Chronic Brain Disease? - 7 months ago FDA Rejects MDMA-Assisted Therapy for PTSD - 8 months ago MDMA for PTSD Under FDA Review; GLP-1 for Opioid Cravings; ADHD an Evolutionary Aid? - about 1 year ago Psychedelics for Psych Conditions Made Their Mark in 2023 - over 1 year ago Another Mid-Stage Psychedelic Win; Gun Suicides Reach High; Magnetic Seizure Therapy - over 1 year ago Psilocybin Shows Promise in Treatment-Resistant Bipolar Type II Depression - over 1 year ago
2	Kyndall Cunningham Vox World explained. techdigital cultureentertainment	Why are so many men doing ayahuasca? - 3 months ago
3	Nicoletta Lanese Live Science Science journalist. New York, USA sciencehealthjournalism	When will MDMA be approved for therapy? Major trial issues may stand in the way, psychiatrist Dr. Albino Oliveira-Maia says. - 4 months ago Shroom compound psilocybin shows promise for bipolar disorder in early trial - over 1 year ago
4	John Pinching PharmaTimes Next-gen biopharma company. La Jolla, California biopharmadrugsdevices	Beckley Psytech announces positive results for ELE-101 in depression trial - 4 months ago
5	James Woodford New Scientist Ocean Correspondent. South Coast, New South Wales oceanjournalismauthorship	Magic mushrooms found in Africa are a species new to science - 4 months ago
6	Meagan Parrish Pharma Voice Senior editor @industrydive. Pharma world follower. Wisconsin, USA pharmaceuticalsjournalismparenting	Psychedelics haven’t fulfilled clinical expectations, but new trial strategies could turn the tide - 4 months ago Despite adcomm rejection, Lykos CEO sees future for MDMA drug - 10 months ago
7	Marissa Plescia MedCity News Reporter at MedCity News. reportingjournalism	4 Things Employers Should Know About Psychedelic Medicines - 5 months ago What’s Next for Psychedelic Medicines? - 5 months ago
8	Meghana Keshavan STAT News Biotech nerd and writer @statnews. biotechwriting	STAT+: Rick Doblin, ‘unleashed,’ blasts FDA over Lykos drug rejection and turns to global push for MDMA therapy - 8 months ago STAT+: Lykos Therapeutics cuts 75% of staff after FDA rejects MDMA-assisted therapy - 8 months ago A tough week for MDMA-assisted psychotherapy - 8 months ago STAT+: Three MDMA therapy papers retracted over data integrity concerns - 8 months ago FDA rejects MDMA as a psychedelic treatment for PTSD - 8 months ago Psychedelic investment continues to ramp up - about 1 year ago
9	Emily Mullin Wired Staff writer at WIRED. Covers biotechnology. Fall 2021 fellow. Pittsburgh, Pennsylvania biotechnology	The Uncertain Path Forward for Psychedelic Medicine - 8 months ago The FDA Just Rejected a Bid for MDMA to Treat PTSD - 8 months ago The Case for MDMA’s Approval Is Riddled With Problems - 10 months ago They Had PTSD. A Psychedelic Called Ibogaine Helped Them Get Better - about 1 year ago
10	Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland televisionentertainment	FDA Declines to Approve MDMA for PTSD - 8 months ago Psychedelic Medicine Could Fill Care Gap in Psychiatric Care - 12 months ago Is 2024 the Year for Psychedelic Medicine? - 12 months ago FDA Accepts New Drug Application for MDMA-Assisted Therapy for PTSD - about 1 year ago

Journalists covering Psilocybin-Assisted Therapy